Samaneh Zandifar
1 , Shokouh Shayanpour
2* 1 Independent Researcher, Isfahan, Iran
2 Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Implication for health policy/practice/research/medical education:
Sodium-glucose cotransporter-2 inhibitors is a promising treatment option for patients with diabetes-associated renal dysfunction.
Please cite this paper as: Zandifar S, Shayanpour S. Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy. J Nephropharmacol. 2023;10(2):e10606. DOI: 10.34172/npj.2023.10606.